Jonathan Rigby - Net Worth and Insider Trading
Jonathan Rigby Net Worth
The estimated net worth of Jonathan Rigby is at least $9 dollars as of 2025-04-27. Jonathan Rigby is the VP, Business Development of Aradigm Corp and owns about 200 shares of Aradigm Corp (ARDMQ) stock worth over $9. Jonathan Rigby is also the President and CEO of SteadyMed Ltd and owns about 0 shares of SteadyMed Ltd (STDY) stock worth over $0. Details can be seen in Jonathan Rigby's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jonathan Rigby has not made any transactions after 2018-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jonathan Rigby
Jonathan Rigby Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan Rigby owns 4 companies in total, including Xeris Biopharma Holdings Inc (XERS) , SteadyMed Ltd (STDY) , and Aradigm Corp (ARDMQ) among others .
Click here to see the complete history of Jonathan Rigby’s form 4 insider trades.
Insider Ownership Summary of Jonathan Rigby
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2019-02-27 | director |
| STDY | SteadyMed Ltd | 2018-08-30 | director & President and CEO |
| ARDMQ | Aradigm Corp | 2006-04-12 | VP & Business Development |
 | | 2021-12-02 | director & Chief Business Officer |
Jonathan Rigby Latest Holdings Summary
Jonathan Rigby currently owns a total of 2 stocks. Among these stocks, Jonathan Rigby owns 200 shares of Aradigm Corp (ARDMQ) as of March 7, 2006, with a value of $9 and a weighting of 100%. Jonathan Rigby also owns 0 shares of SteadyMed Ltd (STDY) as of August 30, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Jonathan Rigby
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARDMQ | Aradigm Corp | 2006-03-07 | 200 | 0.05 | 9 |
| STDY | SteadyMed Ltd | 2018-08-30 | 0 | 4.73 | 0 |
Holding Weightings of Jonathan Rigby
Jonathan Rigby Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan Rigby has made a total of 0 transactions in Aradigm Corp (ARDMQ) over the past 5 years. The most-recent trade in Aradigm Corp is the sale of 0 shares on March 7, 2006, which brought Jonathan Rigby around $0.
According to the SEC Form 4 filings, Jonathan Rigby has made a total of 0 transactions in SteadyMed Ltd (STDY) over the past 5 years. The most-recent trade in SteadyMed Ltd is the sale of 46,565 shares on August 30, 2018, which brought Jonathan Rigby around $207,680.
Insider Trading History of Jonathan Rigby
- 1
Jonathan Rigby Trading Performance
Jonathan Rigby Ownership Network
Ownership Network List of Jonathan Rigby
Ownership Network Relation of Jonathan Rigby
Jonathan Rigby Owned Company Details
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Jonathan Rigby is the director of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include See Remarks Beth Hecht , Chief Financial Officer Steven Pieper , and See Remarks Shannon John Patrick Jr .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Jonathan Rigby made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 25,200 shares made by John P. Schmid , a net sale of 40,000 shares made by Beth Hecht , and a net purchase of 30,769 shares made by Shannon John Patrick Jr .
In summary, during the past 3 months, insiders sold 40,000 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 0 shares, with a net sale of 40,000 shares. During the past 18 months, 40,000 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 94,779 shares were bought by its insiders, resulting in a net purchase of 54,779 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
Jonathan Rigby Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan Rigby. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jonathan Rigby's mailing address is: Hayward Ca 94545.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
